BARIUM SULFATE

N/A

Manufactured by E-Z-EM Canada Inc

781 FDA adverse event reports analyzed

Last updated: 2026-04-15

About BARIUM SULFATE

BARIUM SULFATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by E-Z-EM Canada Inc. The most commonly reported adverse reactions for BARIUM SULFATE include ASPIRATION, NO ADVERSE EVENT, URTICARIA, DIARRHOEA, PRURITUS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for BARIUM SULFATE.

Top Adverse Reactions

ASPIRATION68 reports
NO ADVERSE EVENT32 reports
URTICARIA28 reports
DIARRHOEA27 reports
PRURITUS19 reports
DYSPNOEA18 reports
RENAL FAILURE18 reports
ACUTE KIDNEY INJURY17 reports
VOMITING17 reports
CHRONIC KIDNEY DISEASE15 reports
RASH15 reports
ABDOMINAL PAIN14 reports
COUGH14 reports
NAUSEA13 reports
DRUG HYPERSENSITIVITY12 reports
FATIGUE12 reports
ABDOMINAL DISTENSION11 reports
OFF LABEL USE11 reports
PAIN11 reports
PYREXIA11 reports
ASTHENIA10 reports
DRUG INEFFECTIVE10 reports
HEADACHE10 reports
HYPERSENSITIVITY10 reports
DIZZINESS9 reports
ANXIETY8 reports
PNEUMONIA8 reports
DECREASED APPETITE7 reports
EXPIRED PRODUCT ADMINISTERED7 reports
FALL7 reports
WEIGHT DECREASED7 reports
ABDOMINAL DISCOMFORT6 reports
ABDOMINAL PAIN UPPER6 reports
ANAPHYLACTIC REACTION6 reports
BACK PAIN6 reports
BARIUM IMPACTION6 reports
CONSTIPATION6 reports
DEHYDRATION6 reports
END STAGE RENAL DISEASE6 reports
ERYTHEMA6 reports
HYPERHIDROSIS6 reports
HYPERTENSION6 reports
HYPOTENSION6 reports
PLEURAL EFFUSION6 reports
RESPIRATORY DISORDER6 reports
ADVERSE REACTION5 reports
ANGIOEDEMA5 reports
ARTHRALGIA5 reports
ATRIAL FIBRILLATION5 reports
BURNING SENSATION5 reports
CHILLS5 reports
CONTRAST MEDIA REACTION5 reports
DEATH5 reports
HYPERGLYCAEMIA5 reports
HYPOXIA5 reports
MALAISE5 reports
NEPHROGENIC ANAEMIA5 reports
PNEUMONIA ASPIRATION5 reports
PRODUCT COLOUR ISSUE5 reports
SNEEZING5 reports
ANAEMIA4 reports
BLOOD CREATININE INCREASED4 reports
CARDIAC ARREST4 reports
DEPRESSION4 reports
DRUG INTERACTION4 reports
EPISTAXIS4 reports
FEBRILE NEUTROPENIA4 reports
FEELING ABNORMAL4 reports
FEELING HOT4 reports
GASTROOESOPHAGEAL REFLUX DISEASE4 reports
HEPATIC FAILURE4 reports
ILLNESS4 reports
INSOMNIA4 reports
MALIGNANT NEOPLASM PROGRESSION4 reports
MUSCLE SPASMS4 reports
MYALGIA4 reports
NASAL CONGESTION4 reports
OROPHARYNGEAL PAIN4 reports
OXYGEN SATURATION DECREASED4 reports
PERIPHERAL SWELLING4 reports
PRODUCT QUALITY ISSUE4 reports
RENAL INJURY4 reports
SWELLING FACE4 reports
SYNCOPE4 reports
TACHYCARDIA4 reports
TREMOR4 reports
ACUTE RESPIRATORY DISTRESS SYNDROME3 reports
ANHEDONIA3 reports
APPENDICITIS3 reports
CARDIAC FAILURE CONGESTIVE3 reports
CHEST DISCOMFORT3 reports
CHEST PAIN3 reports
CONVULSION3 reports
DISEASE PROGRESSION3 reports
DYSPHAGIA3 reports
ECONOMIC PROBLEM3 reports
EMOTIONAL DISTRESS3 reports
ENCEPHALOPATHY3 reports
FLATULENCE3 reports
GASTROINTESTINAL PAIN3 reports

Report Outcomes

Out of 421 classified reports for BARIUM SULFATE:

Serious 63.7%Non-Serious 36.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female212 (60.7%)
Male130 (37.2%)
Unknown7 (2.0%)

Reports by Age

Age 5911 reports
Age 6710 reports
Age 639 reports
Age 649 reports
Age 588 reports
Age 748 reports
Age 547 reports
Age 577 reports
Age 617 reports
Age 697 reports
Age 727 reports
Age 466 reports
Age 556 reports
Age 626 reports
Age 656 reports
Age 495 reports
Age 515 reports
Age 535 reports
Age 605 reports
Age 705 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with BARIUM SULFATE?

This profile reflects 781 FDA FAERS reports that mention BARIUM SULFATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for BARIUM SULFATE?

Frequently reported terms in FAERS include ASPIRATION, NO ADVERSE EVENT, URTICARIA, DIARRHOEA, PRURITUS, DYSPNOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures BARIUM SULFATE?

Labeling and FAERS entries often list E-Z-EM Canada Inc in connection with BARIUM SULFATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.